NYSE · Medical - Care Facilities

USPH (USPH) Stock

$78.74 +2.74% NYSE: USPH Healthcare

Valuation

MetricValue
Price$78.74
Market Cap$1.20B
P/E Ratio45.68
P/B Ratio2.07
P/S Ratio1.36
EPS (TTM)$1.42
52-Week High$93.50
52-Week Low$58.19
Dividend Yield2.78%

Financials & Margins

MetricValue
ROE3.15%
ROA1.25%
ROCE10.39%
Gross Margin10.24%
Operating Margin10.24%
Net Margin0.16%
Debt/Equity0.77
Current Ratio1.01

Annual Financials (USD)

Metric20212022202320242025
Revenue$495.0M$553.0M$605.0M$671.0M$781.0M
Operating Profit$71.0M$57.0M$52.0M$63.0M$80.0M
Net Profit$28.0M$28.0M$15.0M$26.0M$15.0M
EPS$4.49$3.34$1.28$1.84$1.42
Op Margin14.3%10.3%8.6%9.4%10.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$749.0M$858.0M$997.0M$1.2B$1.2B
Total Liabilities$297.0M$374.0M$345.0M$408.0M$434.0M
Cash$29.0M$32.0M$153.0M$41.0M$36.0M
Borrowings$223.0M$295.0M$259.0M$295.0M$426.0M

Latest News

USPH: Lowering target price to $67.00 Argus Research · Jul 15, 2026 Outpatient & Specialty Care Stocks Q1 Highlights: U.S. Physical Therapy (NYSE:USPH) StockStory · Jul 13, 2026 How U.S. Physical Therapy’s (USPH) Clinic Acquisition Supports Its Outpatient Care Roll-Up Strategy Insider Monkey · Jul 7, 2026 Astrana Health, Inc. (ASTH) Surges 7.3%: Is This an Indication of Further Gains? Zacks · Jul 2, 2026 U.S. Physical Therapy Announces the Acquisition of a Twelve-Clinic Physical Therapy Practice Business Wire · Jul 2, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$76.0M$59.0M$82.0M$75.0M$75.0M
Investing Cash Flow$-132.0M$-90.0M$-54.0M$-159.0M$-51.0M
Financing Cash Flow$-31.0M$-17.0M$-16.0M$-15.0M$-25.0M
Net Cash Flow$-4.0M$3.0M$121.0M$-111.0M$-6.0M
Free Cash Flow$68.0M$50.0M$73.0M$66.0M$61.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA13.50
FCF Yield6.76%
Quick Ratio1.19
Interest Coverage8.89
Return 1Y-0.95%
Return 3Y-35.85%
Return 5Y-32.11%

Ownership

Insiders Held2.46%
Institutions Held108.21%
Institutions Float Held110.94%
Institutional HolderSharesReport Date
Blackrock Inc.2,208,5112026-03-31
Kayne Anderson Rudnick Investment Management LLC1,065,8562026-03-31
Morgan Stanley1,002,4682026-03-31
Bahl & Gaynor, Inc.845,3882026-03-31
Copeland Capital Management, LLC836,8312026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AHCO $11.17 -0.45% 8.52 $1.52B 0.00%
ASTH $36.33 -0.51% 63.95 $1.80B 0.00%
CNMD $44.24 -0.02% 19.34 $1.33B 1.17%
GDRX $3.12 +2.30% 28.44 $1.08B 0.00%
HCSG $23.30 +0.95% 23.69 $1.60B 0.00%

About USPH

USPH is led by CEO Christopher J. Reading, employs 4,034 people, headquartered in US, publicly traded since 1992.

USPH stock trades at $78.74 with a market capitalization of $1.20B. The stock is valued at a price-to-earnings (P/E) ratio of 45.68, price-to-book of 2.07, price-to-sales of 1.36. Over the past 52 weeks the stock has ranged between $58.19 and $93.50, and currently trades 15.8% below its 52-week high. It pays a dividend yielding 2.78%.

On profitability, USPH generates a return on equity (ROE) of 3.15%, return on capital employed of 10.39%, an operating margin of 10.24%, a net profit margin of 0.16%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides